Evidence map›Paper›PMID 26578515›Full record

ArticleThe Journal of biological chemistry2016

Cell Migration and Invadopodia Formation Require a Membrane-binding Domain of CARMIL2.

M Hunter Lanier, Patrick McConnell, John A Cooper

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Novel CARMIL2 (RLTPR) Mutation Presenting with Hyper-IgE and Eosinophilia: A Case Report.Endocrine, metabolic & immune disorders drug targets · 2024
    Article
  8. Article
  9. High spatial-resolved heat manipulating membrane heterogeneity alters cellular migration and signaling.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M Hunter LanierFrom the Department of Cell Biology and Physiology, Washington University, St. Louis, Missouri 63110.
Patrick McConnellFrom the Department of Cell Biology and Physiology, Washington University, St. Louis, Missouri 63110.
John A CooperFrom the Department of Cell Biology and Physiology, Washington University, St. Louis, Missouri 63110 jacooper@wustl.edu.
Washington University in St. Louis · US

Funding

REGULATION OF ACTIN CAPPING PROTEINR01GM095509 · NIGMS · WASHINGTON UNIVERSITY · PI COOPER, JOHN A · 2012 to 2015
$1.1M
The Role of CARMIL2 in Cell Migration and InvasionF30CA171595 · NCI · WASHINGTON UNIVERSITY · PI LANIER, MICHAEL HUNTER · 2012 to 2014
$105k
NCI NIH HHS F30 CA171595NCI NIH HHS F30CA171595NIGMS NIH HHS GM95509NIGMS NIH HHS R01 GM095509
6 · The paper itself

Abstract

CARMILs regulate capping protein (CP), a critical determinant of actin assembly and actin-based cell motility. Vertebrates have three conserved CARMIL genes with distinct functions. In migrating cells, CARMIL2 is important for cell polarity, lamellipodial assembly, ruffling, and macropinocytosis. In cells, CARMIL2 localizes with a distinctive dual pattern to vimentin intermediate filaments and to membranes at leading edges and macropinosomes. The mechanism by which CARMIL2 localizes to membranes has not been defined. Here, we report that CARMIL2 has a conserved membrane-binding domain composed of basic and hydrophobic residues, which is necessary and sufficient for membrane localization, based on expression studies in cells and on direct binding of purified protein to lipids. Most important, we find that the membrane-binding domain is necessary for CARMIL2 to function in cells, based on rescue expression with a set of biochemically defined mutants. CARMIL1 and CARMIL3 contain similar membrane-binding domains, based on sequence analysis and on experiments, but other CPI motif proteins, such as CD2AP, do not. Based on these results, we propose a model in which the membrane-binding domain of CARMIL2 tethers this multidomain protein to the membrane, where it links dynamic vimentin filaments with regulation of actin assembly via CP.

Indexed as

Adaptor Proteins, Signal TransducingAmino Acid SequenceCell LineCell MembraneCell MovementConserved SequenceCytoskeletal ProteinsDatabases, ProteinHumansHydrophobic and Hydrophilic InteractionsIntermediate FilamentsLiposomesLuminescent ProteinsMicrofilament ProteinsMutationPeptide FragmentsAdaptor Proteins, Signal TransducingCARMIL1 protein, humanCD2-associated proteinCytoskeletal ProteinsLiposomesLuminescent ProteinsMicrofilament ProteinsPeptide FragmentsProtein IsoformsRecombinant Fusion ProteinsVimentinactincapping proteincell migrationcell polarityinvadopodialamellipodialipid bindingplasma membraneRLTPRvimentin

Identifiers

PMID26578515
PMCPMC4714192
OpenAlexW2172917813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.